|
Home > Services (GVK BIO) > Corporate Overview | Corporate Overview
 The exponential increase in the number of targets has created vast opportunities and even greater challenges. More drug candidates must be achieved with shorter times-to-market, making reliable and cost-effective research support a critical factor for success.
At GVK BIO, we provide contract research services to a rapidly growing base of global pharmaceutical and biotechnology companies. We combine Science, Innovation and People to help our clients address their drug development challenges. New frontiers require new ways of working and we believe that to deliver the true promise of science, innovation is necessary. Our customers benefit not just from lower costs and boosted efficiencies, but also from the infusion of fresh ideas and thinking.
GVK BIO is part of the $500 million GVK conglomerate that has operations in infrastructure, services, manufacturing and power. We have a rock-solid foundation and the ability to fund our expansion. This allows us to easily scale up teams and infrastructure in line with project demands. At the same time, we are extremely nimble - responding with agility to changing requirements by anticipating and adding capabilities our clients may need in the future.
| 
